drugset / Trial / NCT04569214

The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients

NCT04569214 ↗

Phase 2 Withdrawn Boston Therapeutics
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to test the efficacy of PAZ320 in diabetic patients.

Timeline

Start
2012-09
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject PAZ320 Unknown — —